FDA delays decision on IBS drug by Ironwood and Forest

04/23/2012 | American City Business Journals

The FDA postponed for three months an approval decision on linaclotide, a drug candidate for irritable bowel syndrome from Ironwood Pharmaceuticals and Forest Laboratories. The companies said the agency asked for further analysis of clinical data.

View Full Article in:

American City Business Journals

Published in Briefs: